The purpose of this study is to analyze motion-induced dose error generated by each tumor motion parameters of irregular tumor motion in helical tomotherapy. To understand the effect of the irregular tumor motion, a simple analytical model was simulated. Moving cases that has tumor motion were divided into a slightly irregular tumor motion case, a large irregular tumor motion case and a patient case. The slightly irregular tumor motion case was simulated with a variability of 10% in the tumor motion parameters of amplitude (amplitude case), period (period case), and baseline (baseline case), while the large irregular tumor motion case was simulated with a variability of 40%. In the phase case, the initial phase of the tumor motion was divided into end inhale, mid exhale, end exhale, and mid inhale; the simulated dose profiles for each case were compared. The patient case was also investigated to verify the motion-induced dose error in 'clinical-like' conditions. According to the simulation process, the dose profile was calculated. The moving case was compared with the static case that has no tumor motion. In the amplitude, period, baseline cases, the results show that the motion-induced dose error in the large irregular tumor motion case was larger than that in the slightly irregular tumor motion case or regular tumor motion case. Because the offset effect was inversely proportion to irregularity of tumor motion, offset effect was smaller in the large irregular tumor motion case than the slightly irregular tumor motion case or regular tumor motion case. In the phase case, the larger dose discrepancy was observed in the irregular tumor motion case than regular tumor motion case. A larger motion-induced dose error was also observed in the patient case than in the regular tumor motion case. This study analyzed motion-induced dose error as a function of each tumor motion parameters of irregular tumor motion during helical tomotherapy. The analysis showed that variability control of irregular tumor motion is important. We believe that the variability of irregular tumor motion can be reduced by using abdominal compression and respiratory training.
Introduction
Tumor motion caused by respiration produces motion-induced dose errors in radiation therapy. [1] [2] [3] The motion-induced dose error presents additional complications in helical tomotherapy, as the tumor motion interacts with the couch motion. 4, 5) Owing to the tumor motion, the treatment field does not reach the tumor region constantly, and repeatedly shifts in and out of the tumor area. 6, 7) This effect prevents the delivery of the planned dose to the tumor region. 8, 9) Typically, gating or tracking techniques are used to solve this problem in LINAC or cyberknife. [10] [11] [12] However, the use of such techniques is limited in helical tomotherapy, as the gantry and couch continuously move during the treatment. Many previous studies have focused on this issue.
Dose profiles according to the changes of the field widths and gantry rotation periods have been reported. 5) As a result of this study, 5 cm of field width exhibited better gamma passing rates than 1 cm and 2.5 cm widths in the gamma comparisons with 2% dose discrepancy and 2 mm distance-to-agreement. In a different study focused on couch motion, 7) the couch motion was varied within a range of values, and the effects on the dose profiles were assessed. Furthermore, different dose profiles in relation to the initial phase of the tumor motion have been shown. 6) Many studies related to this issue have used 'regular' and 'sinusoidal' waveforms to represent the tumor motion, and these limitations have been shown to be significant. However, in reality, the tumor motion has an 'irregular'
waveform. Therefore, the aim of this study is to analyze motion-induced dose error generated by tumor motion parameters of irregular tumor motion in helical tomotherapy.
Materials and Methods

Theory to acquire the dose profile
To understand the effects of the irregular tumor motion of a target, a simple one-dimensional model was simulated (Fig. 1) .
The target was modeled as a rigid line. The treatment field (W), which is blocked by two jaws, represented the treatment field exposed in helical tomotherapy. We denoted the positions of the treatment field caused by the couch motion and tumor motion as '  ' and '  ', respectively. A more detailed explanation is presented in the following section.
1) Tumor coordinate system: In this study, a tumor coordinate system was used to explain the acquisition process of the dose profile and analyze the motion-induced dose errors.
4)
The tumor coordinate system is different from the room coordinate system normally used. The treatment room is the standard in the room coordinate system; therefore, the target is moved by the tumor motion, and the couch is moved in the superior-inferior (SI) direction with constant velocity (Fig. 2a) .
Conversely, as the tumor is the standard in the tumor coordinate system (Fig. 2b) , the target dose does not move while the treatment field undergoes a complex motion.
2) Static dose acquisition: To produce the dose profiles ( 69 report and many related papers were considered during the film measurement. [13] [14] [15] SI direction curves of the calibrated image were collected, and a curve at the isocenter was selected to determine the 'static dose' (). ImageJ v1.48 (US National
Institutes of Health) and Matlab (version R2012b, Mathworks, Natick, MA, USA) softwares were used in the process of calibration and acquiring static dose.
3) Position of treatment field acquisition: The position of the treatment field, which is caused by the couch motion   , can be written as a function of time t:
where   is the initial position at which the static dose starts to accumulate and  is the velocity of the couch. As a tumor coordinate system was used, the position of the radiation field moved in opposite direction to that of the couch motion (Fig. 2) .
To improve the accuracy, all the tumor motions were generated by an internet accessible respiratory trace generator (RTG) (http://www.ucalgary.ca/rop/Research/Respiratory). 16) In addition, the RTG could produce specific tumor motions for which a specific tumor motion parameter was irregular. For example, to produce tumor motion for which only the amplitude is irregular, the RTG could generate a tumor motion with an amplitude in the range of 1.35∼1.65 cm and a period of 4 s.
As for   , the opposite direction of the tumor motion (  ) was used to calculate the position of the treatment field.
The position of the treatment field   caused by the couch motion and tumor motion was calculated as a function of time t: where    is the same as that in Equation (1) and    is the tumor motion produced by the RTG (Fig. 2) and    is the position of the treatment field caused by the tumor motion.
4) Dose profile acquisition:
To acquire the dose profile, the position of the treatment field was changed as a function of time, and the static doses were cumulated (Fig. 1) . The dose profile can be expressed as:
where  is dose profile,    is static dose at the position of the treatment field   (same as that in Equation (2)),   is the time at which the static dose started accumulating, and   is the time at which the static dose stopped accumulating.
Methods
The resulting dose profile depended on four tumor motion parameters, i.e., amplitude, period, baseline, and initial phase.
The moving case (experimental group) and static case (control group) were set to confirm the motion-induced dose error. The moving case was set to produce a dose profile that has a mo- assumed for a tumor motion generated by normal breathing and 40% for a tumor motion generated by deep breathing.
17)
The phase case concerned the initial phase of the tumor motion, which was divided into end inhale, mid exhale, end exhale, and mid inhale. The tumor motions of a regular tumor motion case and a patient case were used to compare the discrepancy effects of the tumor motion. The second category comprises the patient case, in which all the tumor motion parameters are irregular.
The tumor motion for each moving case was calculated according to Equation (2) . The dose profiles were acquired by adding the calculated position of the treatment field (Equation (3)). More details on the conditions adopted to calculate the dose profile are given in Table 2 .
To analyze the motion-induced dose error, the dose profiles were evaluated for all the points. The amplitude, period, baseline, and patient cases were compared with the static case, and the maximum dose discrepancy between the moving case and static case was investigated. In the phase case, the end inspiration, mid expiration, end expiration, and mid inspiration phases of the tumor motion were compared. The position versus time curve of the treatment field was used to investigate the causes of the motion-induced dose error (Fig. 2 ).
Results and Discussion areas were generated by the curves of the static case and moving case. This effect caused an accumulation of the static dose at different positions. In the regular tumor motion case, the 'in' and 'out' areas were identical. Therefore, an offset effect was generated, allowing the reduction of the motion-induced dose error. However, in the amplitude case, the tumor motion amplitude varied irregularly and appeared smaller or larger than that in the regular tumor motion case. Consequently, smaller, or larger, 'in' and 'out' areas were generated. This effect reduced the offset effect, and the generated motion-induced dose error was larger than that observed in the regular tumor motion case. 5a shows the effects on the motion-induced dose error in the baseline case. In the slightly irregular motion case, the maximum dose discrepancy was 6.9%, whereas, in the large irregular motion case, the maximum error was 15.9%. In the large irregular tumor motion case, the motion-induced dose error was greater than that in the slightly irregular tumor motion case. In the baseline case, the effects observed in the amplitude case and period case were generated at the same time.
Therefore, we believe that the baseline drift can have a significant impact.
Motion-induced dose errors according to the initial phase
The motion-induced dose error can also be observed in the initial phase of a tumor motion. Fig. 6 shows that the dose profile changed depending on the different initial phase of a tumor motion. For a regular tumor motion, the maximum dose discrepancy between the initial phases of a tumor motion was approximately 0.7%, whereas a value of 1.3% was observed for the irregular motion. A different dose discrepancy was observed at different positions of the curve. In the patient case, the motion-induced dose error was larger than that in the regular tumor motion case. To reduce the motion-induced dose error, the effect of the tumor motion initial phase should be considered.
Motion-induced dose errors in the patient case
In the patient case, the effects of the tumor motion parameters (amplitude, period, and baseline) generated motion-induced dose errors (Fig. 7a) . A maximum 15.0% dose error was observed in the patient case. Fig. 7b reveals the reason of the motion-induced dose error. Owing to the effects of the tumor motion parameters, the offset effect was not generated in the regular tumor motion case, causing a significant motion-induced dose error.
To reduce the motion-induced dose errors, it is necessary to reduce the variability of the tumor motion parameters. The current clinically applicable methods based on abdominal compression and respiratory training seem to provide appropriate solutions to minimize the tumor motion.
In this study, we analyzed the motion-induced dose error generated by irregular tumor motion. The motion-induced dose error observed in the irregular tumor motion case was larger than those seen in the slightly irregular tumor motion and regular tumor motion cases. Consequently, we believe that the motion-induced dose error generated by a "large irregular" tumor motion can be greater than that of a regular tumor motion.
Even though this result was acquired by simplifying the treatment field geometry and tumor motion, it still helps intuitively understand the relationship between the irregular tumor motion and motion-induced dose error. 
Conclusion
In this study, motion-induced dose error as a function of each tumor motion parameters of irregular tumor motion during helical tomotherapy was investigated. The analysis showed that variability control of irregular tumor motion is important.
We believe variability of irregular tumor motion can be reduced by using abdominal compression and respiratory training.
This study may help understand the effects of the tumor motion parameters on the dose profile.
